Vlažna forma senilne degeneracije makule (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vlažna forma senilne degeneracije makule" in Serbian language version.

refsWebsite

Global rank Serbian rank

2^nd place

4^th place

5^th place

12^th place

low place

low place

1web.archive.org

1^st place

1^st place

doi.org

dx.doi.org

„Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration”. New England Journal of Medicine. 364 (20): 1897—1908. 2011-05-19. ISSN 0028-4793. doi:10.1056/nejmoa1102673.
Gillies, Mark C.; Daien, Vincent; Nguyen, Vuong; Barthelmes, Daniel (2017). „Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123;1751–1761)”. Ophthalmology. 124 (3): e31—e32. ISSN 0161-6420. doi:10.1016/j.ophtha.2016.05.054.

doi.org

„Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration”. New England Journal of Medicine. 364 (20): 1897—1908. 2011-05-19. ISSN 0028-4793. doi:10.1056/nejmoa1102673.
Gillies, Mark C.; Daien, Vincent; Nguyen, Vuong; Barthelmes, Daniel (2017). „Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123;1751–1761)”. Ophthalmology. 124 (3): e31—e32. ISSN 0161-6420. doi:10.1016/j.ophtha.2016.05.054.

rcophth.ac.uk

The Royal College of Ophthalmologists. Age-related macular degeneration: guidelines for management; 2013. http://www.rcophth.ac.uk/wp-content/uploads/2014/12/2013-SCI-318-RCOphth-AMD-Guidelines-Sept-2013-FINAL-2.pdf Архивирано на сајту Wayback Machine (12. фебруар 2020) Accessed July 8, 2019.

web.archive.org

The Royal College of Ophthalmologists. Age-related macular degeneration: guidelines for management; 2013. http://www.rcophth.ac.uk/wp-content/uploads/2014/12/2013-SCI-318-RCOphth-AMD-Guidelines-Sept-2013-FINAL-2.pdf Архивирано на сајту Wayback Machine (12. фебруар 2020) Accessed July 8, 2019.

worldcat.org

„Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration”. New England Journal of Medicine. 364 (20): 1897—1908. 2011-05-19. ISSN 0028-4793. doi:10.1056/nejmoa1102673.
Gillies, Mark C.; Daien, Vincent; Nguyen, Vuong; Barthelmes, Daniel (2017). „Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123;1751–1761)”. Ophthalmology. 124 (3): e31—e32. ISSN 0161-6420. doi:10.1016/j.ophtha.2016.05.054.